An integrated approach in the treatment of a patient with chronic destructive pulmonary tuberculosis with extensively drug-resistant pathogen

A clinical example demonstrating the need for a comprehensive approach in the treatment of patients with chronic tuberculosis and extensively drug-resistant pathogen is presented. The patient repeatedly had relapses of a specific process, despite ongoing anti-tuberculosis therapy for several years. During this period, drug resistance to the new anti-tuberculosis drug bedaquiline was formed, which significantly reduces the possibility of selecting adequate anti-tuberculosis therapy. In addition, the patient has a widespread tuberculous process of the trachea and bronchi, accompanied by massive bacterial excretion. Against the background of the complex treatment, by the 6th month of treatment, it was possible to achieve pronounced positive dynamics, however, a massive fibrous cavity remained in the right lung. Given the low functional parameters limiting the use of resection surgery, the patient was able to undergo collapsosurgical treatment in the form of extrapleural pneumonitis

Authors

Institutions

Publication Details

Journal
Vrach
Published
2024-11-19
DOI
https://doi.org/10.29296/25877305-2024-11-12
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

An integrated approach in the treatment of a patient with chronic destructive pulmonary tuberculosis with extensively drug-resistant pathogen

N. Chernykh, N.V. Chumovatov, A. Aynsanova
Vrach
Tuberculosis Research and Epidemiology
article

An integrated approach in the treatment of a patient with chronic destructive pulmonary tuberculosis with extensively drug-resistant pathogen

N. Chernykh, N.V. Chumovatov, A. Aynsanova
article en

Abstract

A clinical example demonstrating the need for a comprehensive approach in the treatment of patients with chronic tuberculosis and extensively drug-resistant pathogen is presented. The patient repeatedly had relapses of a specific process, despite ongoing anti-tuberculosis therapy for several years. During this period, drug resistance to the new anti-tuberculosis drug bedaquiline was formed, which significantly reduces the possibility of selecting adequate anti-tuberculosis therapy. In addition, the patient has a widespread tuberculous process of the trachea and bronchi, accompanied by massive bacterial excretion. Against the background of the complex treatment, by the 6th month of treatment, it was possible to achieve pronounced positive dynamics, however, a massive fibrous cavity remained in the right lung. Given the low functional parameters limiting the use of resection surgery, the patient was able to undergo collapsosurgical treatment in the form of extrapleural pneumonitis

Vrach
Central Research Institute (IN), Central Scientific Research Institute of Tuberculosis Russian Academy of Medical Sciences (RU)
Good health and well-being
Openalex Percentile: Top 74%
Tuberculosis Research and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.